![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ultrasis | LSE:ULT | London | Ordinary Share | GB0001494979 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.095 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
26/9/2018 16:45 | hi wooly here will be no worries with OPTI, wooly the news flow should give you confidence, just think in a few years time it will be a billion £ company thats £11+ per share, i cant wait | ![]() humphries1 | |
26/9/2018 16:15 | hi wooly watched it a while ago tried to put it on the thread but ADVFN wont allow proactive link on the site HOW PETTY | ![]() humphries1 | |
26/9/2018 15:34 | hi wooly dont know if you have seen this www.proactiveinvesto | ![]() humphries1 | |
26/9/2018 14:49 | wooly you coundnt timed that any better could you buy yesterday and news today, the OPTI thread has gone to pot thats why ELRIC started the blog | ![]() humphries1 | |
26/9/2018 11:34 | Hope so mate, we can chat here without OPTI idiots :) | wulwirth | |
26/9/2018 08:24 | magic wooly we are in for a very good ride there is no doubt about that | ![]() humphries1 | |
25/9/2018 23:00 | SMITH AND WILLIAMS RUNNING THE SHOW 2018 - INCLUDING 365 HEALTH. | wulwirth | |
25/9/2018 21:00 | In humph :) | wulwirth | |
25/9/2018 16:21 | never mind wooly hope you get it over next couple of days, i tell you what wooly ohara knows a hell of a lot more than we do LOL | ![]() humphries1 | |
25/9/2018 09:02 | hi wooly did you manage get any | ![]() humphries1 | |
24/9/2018 13:58 | Its right humph limit order in bid 95p :) | wulwirth | |
24/9/2018 13:42 | hi wooly i can understand that you have to feel its right for you | ![]() humphries1 | |
24/9/2018 11:11 | And here's me dithering on the side, really lost my bottle :) | wulwirth | |
24/9/2018 07:23 | hi wooly more news from OPTI 24 September 2018 OptiBiotix Health plc ("OptiBiotix" or the "Company") Formation of ProBiotix Health Limited Appointment of Adam Reynolds as Chairman OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol and skin care, announces the formation of a 100% owned subsidiary, ProBiotix Health Limited ("ProBiotix"), and appointment of Adam Reynolds as Non-Executive Chairman to ProBiotix's Board. In July 2016, OptiBiotix announced a strategy to develop its technology platforms into separate divisions; each containing its own technology platform, intellectual property portfolio and partner agreements. In due course these divisions could become separate legal entities with the potential for a separate public listing. The first step in this strategy was commenced in March 2016 when OptiBiotix formed SkinBiotix Limited, which was admitted as Skinbiotherapeutics plc to AIM in April 2017. The listing of Skinbiotherapeutics plc materialised the value of a part of the business in which a 52% stake was acquired by OptiBiotix for GBP250K in March 2016 and which now has a market valuation of around GBP24m, with OptiBiotix(R) owning a 41.9% shareholding (GBP11.7m). OptiBiotix's Probiotic division containing its cholesterol and blood pressure reducing strain LP(LDL) (R) has made strong progress with 14 commercial deals in just under 18 months and a large deal pipeline. This division uses its high throughput OptiScreen(R) technology for the identification of probiotics with specific health benefits as supplements or therapeutic products. OptiBiotix directors believe that this division has now reached a stage of scientific and commercial maturity with growing revenue streams where it may be advantageous to form a 100% owned subsidiary, called ProBiotix Health Ltd, with the potential for a separate public listing. The appointment of Adam Reynolds as Non-Executive Chairman to ProBiotix's Board brings a track record of increasing shareholder value and leadership in building a team with a view to seeking an Initial Public Offering. Stephen O'Hara, CEO of OptiBiotix, commented: "The formation of ProBiotix Health Limited and appointment of Adam Reynolds as Chairman continues a successful strategy of building value in each division which is materialised by forming separate legal entities and taking them to a public listing. As the listed company grows in value using its own funds, OptiBiotix shareholders benefit from the appreciation of the asset as exemplified by SkinBiotherapeutics plc. We are delighted to welcome Adam Reynolds as Chairman of ProBiotix as he brings extensive experience of equity markets and a proven record of taking companies to IPO. This is an innovative business model which over time looks to give OptiBiotix shareholders a position in multiple companies, and with it the prospect of multiple returns." | ![]() humphries1 | |
24/9/2018 07:11 | wow wooly there is some amount of reading in that lot. i read a paper a scientist wrote he recons that depression could be treated through the bacteria in the guts, so there is a chance that OPTIBIOTIX might be able to get round to treating it in the future WOW what a fantastic thing if we could | ![]() humphries1 | |
23/9/2018 10:58 | humph this dropped in my inbox this morning someone trying to remind me lol. | wulwirth | |
23/9/2018 07:38 | cheers wooly with the news due i realy cant see it at this level for long, and as i said to my mate it will be a £12 billion + company so a few pence here or there isnt worth thinking about. watched the fight last night didnt expect it to end so soon, wait for grove fight now | ![]() humphries1 | |
23/9/2018 00:27 | 6 month chart shows a bounce and a possible support level, but a 12 month chart shows a downward trend, next week will offer a further insight imo :) Good luck humph | wulwirth | |
22/9/2018 17:39 | hi wooly one of my sons has a KODI box the other has a PLEX box, i use smart phone GALAXY S8 and a CHROMECAST 2 (£30 from argos) fixes to back of tv and i can stream all sports from S8 to tv using wifi, i will watch the @@@@@ tonight, i have KODI on my phone as well and on the pc to, i use the KODI on my phone more than the one on the pc. a very nice buy went through on OPTI on friday at diner time 65,000 @ 93p how i wish it was mine, i was telling a mate of mine to topup friday morning but he could not get to a pc to topup so he is going to try monday morning. what does the chart say wooly for monday morning, some people swear by charts and trade by them, i would not think of trading OPTI. one of my grandsons is thinking of buying into OPTI but wont have any spare cash till the new year i have told him they will be £2 by then, lets see if i am right, itl be a first if i am right LOL. | ![]() humphries1 | |
22/9/2018 13:54 | £2 humph the ramper lol, sure its possible with good income news, had a kodi box went out of date flogged it on ebay, correction gave it away on ebay haha, one bid means its no longer an auction, that's the way its been this year! If you list for 99p there's chance of a last minute sniper who steals it. | wulwirth | |
21/9/2018 08:15 | hi wooly yes clay did a lot for boxing, it used to be toe to toe till he came along and showed the world how it should be done, a lot of people are using there smart phones and a small unit fits to back of tv called a CHROMECAST 2 to stream live sports to the tv using a few apps on your phone like KODI and TV TAP and MOBDRO i can go on. looking for the next rise on OPTI tell me when its heading for £2 | ![]() humphries1 | |
20/9/2018 17:12 | Looking at the chart still could be right, no visible support as is, it needs a positive RNS humph and away you go imo. | wulwirth |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions